Stay updated on Belantamab vs Bortezomib in MM Clinical Trial
Sign up to get notified when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.

Latest updates to the Belantamab vs Bortezomib in MM Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has removed detailed information about a clinical study on multiple myeloma, including its design, inclusion and exclusion criteria, and the names of the investigational drugs involved. A new version number has been added, indicating an update to the document.SummaryDifference18%
- Check30 days agoChange DetectedThe page has updated its version from v2.14.3 to v2.14.4 and removed a date of March 25, 2025, while adding two new dates: February 17, 2025, and March 18, 2025.SummaryDifference0.3%
- Check37 days agoChange DetectedThe page has been updated to reflect a new revision version (v2.14.3) and has removed estimated dates for postings, replacing them with actual dates.SummaryDifference0.3%
- Check44 days agoChange DetectedThe web page has updated the study's location details, reducing the number of locations from 130 to 119, and has added new locations in various countries. Additionally, the results reporting dates have been clarified, with specific dates for submissions and postings.SummaryDifference71%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
Stay in the know with updates to Belantamab vs Bortezomib in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.